114501-02-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
2-[(2-Methoxyphenyl)amino]nicotinic acid is used as a potential therapeutic agent for its anti-inflammatory and antioxidant properties, making it a candidate for the treatment of various diseases.
Used in Cancer Treatment:
In the field of oncology, 2-[(2-Methoxyphenyl)amino]nicotinic acid is used as a potential treatment for various types of cancer, given its ability to modulate biological processes that may contribute to cancer progression.
Used in Cardiovascular Disorders:
2-[(2-Methoxyphenyl)amino]nicotinic acid is utilized in the research and development of treatments for cardiovascular disorders, due to its potential to impact the underlying mechanisms of these conditions.
Used in Immune System Modulation:
2-[(2-METHOXYPHENYL)AMINO]NICOTINIC ACID is used in the study and potential regulation of the immune system, with the aim of reducing inflammation and managing immune responses in various biological processes.
Overall, 2-[(2-Methoxyphenyl)amino]nicotinic acid is a versatile compound with a broad spectrum of potential applications in the medical and pharmaceutical industries, warranting further research and development to harness its therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 114501-02-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,5,0 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 114501-02:
(8*1)+(7*1)+(6*4)+(5*5)+(4*0)+(3*1)+(2*0)+(1*2)=69
69 % 10 = 9
So 114501-02-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H12N2O3/c1-18-11-7-3-2-6-10(11)15-12-9(13(16)17)5-4-8-14-12/h2-8H,1H3,(H,14,15)(H,16,17)/p-1
114501-02-9Relevant academic research and scientific papers
Misbahi, Houria,Brouant, Pierre,Barbe, Jacques
, p. 335 - 336 (2003)
Several 2-anilinonicotinic acid derivatives were prepared under the Ullmann's reaction conditions by condensation of 2-chloronicotinic acid and various substituted anilines. Improvement of the procedure based on the effect of the catalyst and that of the
Antiallergy Agents. 1. Substituted 1,8-Naphthyridin-2(1H)-ones as Inhibitors of SRS-A Release
Sherlock, Margaret H.,Kaminski, James J.,Tom, Wing C.,Lee, Joe F.,Wong, Shing-Chun,et al.
, p. 2108 - 2121 (2007/10/02)
A novel class of antiallergy agents, the substituted 1,8-naphthyridin-2(1H)-ones, is described.The present compounds are orally active, potent inhibitors of allergic and nonallergic bronchospasm in animal models.Structure-activity studies of the lead compound in this sereis, 1-phenyl-3-n-butyl-4-hydroxynaphthyridin-2(1H)-one (11), identified three compounds of interest, 1-phenyl-3-(2-propenyl)-4-acetoxy-1,8-naphthyridin-2(1H)-one (12), 1-(3'-chlorophenyl)-3-(2-propenyl)-4-acetoxy-1,8-naphthyridin-2(1H)-one (87), and 1-(3'-methoxyphenyl)-3-(2-propenyl)-4-acetoxy-1,8-naphthyridin-2(1H)-one (89).The mechanism of antiallergy activity may involve inhibition of the release of the sulfidopeptide leukotrienes. 1-Phenyl-3-(2-propenyl)-4-acetoxy-1,8-naphthyridin-2(1H)-one, Sch 33303 (12), was selected for preclinical development as an antiallergy agent.
